News and Stories About Precision Promise

Every day in 2021, 166 Americans will learn that they have pancreatic cancer. That’s 60,430 people who are predicted to […]
READ MORE

Editor’s note: January is Pancreatic Cancer Clinical Trials Awareness Month. Today’s article describes the complex and changing landscape of clinical […]
READ MORE

Editor’s note: Today’s article looks back at scientific and clinical advances made in 2020 and kicks off our Year in […]
READ MORE

Get a recap of our World Pancreatic Cancer Day webinar featuring an expert panel discussing the latest in clinical research […]

Adaptive Clinical Trial Design Provides A More Cost Effective, Efficient, and Patient-Centric Approach to Clinical Development Los Angeles, Calif. – […]
READ MORE

We recently announced that our groundbreaking new approach to pancreatic cancer clinical trials – PanCAN’s Precision PromiseSM – is open […]
READ MORE

Adaptive Clinical Trial Design Is More Cost Effective, Patient-Centric and Allows for Faster Learning Than Standard Trials Los Angeles, Calif. […]
READ MORE

“The standard clinical trial system is not working fast enough for pancreatic cancer patients.” — Julie Fleshman, JD, MBA, PanCAN […]
READ MORE

The Pancreatic Cancer Action Network’s (PanCAN) Annual Scientific Summit may have looked different this year, but some things stayed the […]
READ MORE

“Accelerating Personalized Care” was the theme for the 2020 Gastrointestinal (GI) Cancers Symposium, which took place Jan. 23-25 in San […]
READ MORE

Editor’s note: This article kicks off our 2019 Year in Review series – highlighting the research advancements that you – […]
READ MORE

Clinical trials are necessary to determine whether a drug or treatment combination is safe, effective and an improvement over the […]
READ MORE

Editor’s note: Pancreatic Cancer Action Network (PanCAN) President and CEO Julie Fleshman attended the Harvard Business School (HBS) Kraft Precision […]
READ MORE

The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) took place earlier this week in Berlin. The […]
READ MORE

The Pancreatic Cancer Action Network (PanCAN) is excited to launch Precision PromiseSM in 2019. Precision Promise is the first adaptive […]
READ MORE

Entrepreneur Skip Viragh was a collaborator. An innovator. A proactive problem-solver. A masterful leader. And he deeply valued these qualities […]
READ MORE

“Let’s face it: The pancreas is a behind-the-scenes organ most of us don’t know – or think – much about. […]
READ MORE

Congratulations to Pancreatic Cancer Action Network (PanCAN) partner Tempus, a technology company building the world’s largest library of molecular and […]
READ MORE

Yesterday, Medscape published a feature story detailing the science behind pancreatic cancer. The article recounts the devastating statistics of the […]
READ MORE

Meet Vincent Picozzi, Jr., MD, director of the pancreaticobiliary program at the Floyd & Delores Jones Cancer Institute at Virginia […]
READ MORE

Last month we welcomed Victoria Manax Rutson, MD, to our team as our first Chief Medical Officer! The need for […]
READ MORE

Earlier this week we announced Precision Promise, the first large-scale precision medicine trial that will put the patient at the […]
READ MORE

Today is a milestone for our organization and the pancreatic cancer community. We have made a promise to transform outcomes […]
READ MORE